Optimal Management of Opioid Induced Constipation

Gerald Sacks, MD, and Fariborz Rezai, MD, FCCP FCCM, review currently available treatment options for the management of opioid-induced constipation.

EP. 1: Overview of Opioid-Induced Constipation (OIC)

June 3rd 2021

Gerald Sacks, MD, discusses the pathophysiology of opioid-induced constipation (OIC) and provides insight on common medical conditions that often lead to OIC.

EP. 2: Diagnosis of Opioid-Induced Constipation

June 3rd 2021

Gerald Sacks, MD, and Fariborz Rezai, MD, FCCP FCCM, review the diagnosis of opioid-induced constipation and goals of treatment.

EP. 3: Role of Methylnaltrexone in OIC Management

June 10th 2021

A discussion on the use of oral methylnaltrexone for the treatment of opioid-induced constipation in patients with chronic non-cancer pain and the implications for clinical practice.

EP. 4: Using PAMORAs for OIC Treatment

June 10th 2021

Gerald Sacks, MD, and Fariborz Rezai, MD, FCCP FCCM, share their approach to selecting PAMORAs in clinical practice for the optimal management of opioid-induced constipation.

EP. 5: Additional Treatment Options for OIC Management

June 17th 2021

The role of lifestyle modifications and over-the-counter products to prevent opioid-induced constipation in patients is discussed.

EP. 6: Patient Provider Communication for Managing OIC

June 17th 2021

Gerald Sacks, MD, and Fariborz Rezai, MD, FCCP, FCCM, share their personal experience in approaching and openly communicating the management of opioid-induced constipation with patients.

EP. 7: Addressing Opioid-Induced Constipation With Patients

June 24th 2021

Fariborz Rezai, MD, FCCP FCCM, comments on the importance of being proactive in addressing opioid-induced constipation early on with patients and shares advice for providers.

EP. 8: Unmet Needs in OIC Management 

June 24th 2021

Gerald Sacks, MD, and Fariborz Rezai, MD, FCCP FCCM, discuss unmet needs and the future treatment landscape in managing opioid-induced constipation.